Deidra C Crews1,2,3, Tanushree Banerjee4, Donald E Wesson5, Hal Morgenstern6, Rajiv Saran7,8, Nilka Ríos Burrows9, Desmond E Williams10, Neil R Powe4,11. 1. Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 2. Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. 3. Johns Hopkins Center for Health Equity, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. 4. Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, California, USA. 5. Diabetes Health and Wellness Institute, Baylor Scott and White Health, Dallas, Texas, USA. 6. Departments of Epidemiology and Environmental Health Sciences, School of Public Health, and Department of Urology, Medical School, University of Michigan, Ann Arbor, Michigan, USA. 7. Kidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, Michigan, USA. 8. Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA. 9. Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 10. Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 11. Department of Medicine, San Francisco General Hospital, San Francisco, California, USA.
Abstract
BACKGROUND: Dietary acid load (DAL) contributes to the risk of CKD and CKD progression. We sought to determine the relation of DAL to racial/ethnic differences in the risk of end-stage renal disease (ESRD) among persons with CKD. METHODS: Among 1,123 non-Hispanic black (NHB) and non-Hispanic white (NHW) National Health and Nutrition Examination Survey III participants with estimated glomerular filtration rate 15-59 mL/min/1.73 m2, DAL was estimated using the Remer and Manz net acid excretion (NAEes) formula and 24-h dietary recall. ESRD events were ascertained via linkage with Medicare. A competing risk model (accounting for death) was used to estimate the hazard ratio (HR) for treated ESRD, comparing NHBs with NHWs, adjusting for demographic, clinical and nutritional factors (body surface area, total caloric intake, serum bicarbonate, protein intake), and NAEes. Additionally, whether the relation of NAEes with ESRD risk varied by race/ethnicity was tested. RESULTS: At baseline, NHBs had greater NAEes (50.9 vs. 44.2 mEq/day) than NHWs. It was found that 22% developed ESRD over a median of 7.5 years. The unadjusted HR comparing NHBs to NHWs was 3.35 (95% CI 2.51-4.48) and adjusted HR (for factors above) was 1.68 (95% CI 1.18-2.38). A stronger association of NAE with risk of ESRD was observed among NHBs (adjusted HR per mEq/day increase in NAE 1.21, 95% CI 1.12-1.31) than that among NHWs (HR 1.08, 95% CI 0.96-1.20), p interaction for race/ethnicity × NAEes = 0.004. CONCLUSIONS: Among US adults with CKD, the association of DAL with progression to ESRD is stronger among NHBs than NHWs. DAL is worthy of further investigation for its contribution to kidney outcomes across race/ethnic groups.
BACKGROUND:Dietary acid load (DAL) contributes to the risk of CKD and CKD progression. We sought to determine the relation of DAL to racial/ethnic differences in the risk of end-stage renal disease (ESRD) among persons with CKD. METHODS: Among 1,123 non-Hispanic black (NHB) and non-Hispanic white (NHW) National Health and Nutrition Examination Survey III participants with estimated glomerular filtration rate 15-59 mL/min/1.73 m2, DAL was estimated using the Remer and Manz net acid excretion (NAEes) formula and 24-h dietary recall. ESRD events were ascertained via linkage with Medicare. A competing risk model (accounting for death) was used to estimate the hazard ratio (HR) for treated ESRD, comparing NHBs with NHWs, adjusting for demographic, clinical and nutritional factors (body surface area, total caloric intake, serum bicarbonate, protein intake), and NAEes. Additionally, whether the relation of NAEes with ESRD risk varied by race/ethnicity was tested. RESULTS: At baseline, NHBs had greater NAEes (50.9 vs. 44.2 mEq/day) than NHWs. It was found that 22% developed ESRD over a median of 7.5 years. The unadjusted HR comparing NHBs to NHWs was 3.35 (95% CI 2.51-4.48) and adjusted HR (for factors above) was 1.68 (95% CI 1.18-2.38). A stronger association of NAE with risk of ESRD was observed among NHBs (adjusted HR per mEq/day increase in NAE 1.21, 95% CI 1.12-1.31) than that among NHWs (HR 1.08, 95% CI 0.96-1.20), p interaction for race/ethnicity × NAEes = 0.004. CONCLUSIONS: Among US adults with CKD, the association of DAL with progression to ESRD is stronger among NHBs than NHWs. DAL is worthy of further investigation for its contribution to kidney outcomes across race/ethnic groups.
Authors: Teresa K Chen; Michael J Choi; W H Linda Kao; Brad C Astor; Julia J Scialla; Lawrence J Appel; Liang Li; Michael S Lipkowitz; Myles Wolf; Rulan S Parekh; Cheryl A Winkler; Michelle M Estrella; Deidra C Crews Journal: Clin J Am Soc Nephrol Date: 2015-10-01 Impact factor: 8.237
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Amber E Johnson; L Ebony Boulware; Cheryl A M Anderson; Tatpong Chit-ua-aree; Kimberly Kahan; LaPricia Lewis Boyér; Yang Liu; Deidra C Crews Journal: BMC Nephrol Date: 2014-12-06 Impact factor: 2.388
Authors: DengFeng Li; James A Snipes; Mariana Murea; Anthony J A Molina; Jasmin Divers; Barry I Freedman; Lijun Ma; Snezana Petrovic Journal: Am J Nephrol Date: 2020-08-31 Impact factor: 3.754
Authors: Mindy Pike; Thomas G Stewart; Jennifer Morse; Patrick Ormsby; Edward D Siew; Adriana Hung; Khaled Abdel-Kader; T Alp Ikizler; Loren Lipworth; Cassianne Robinson-Cohen Journal: Kidney Int Rep Date: 2019-04-04
Authors: Nwamaka D Eneanya; L Ebony Boulware; Jennifer Tsai; Marino A Bruce; Chandra L Ford; Christina Harris; Leo S Morales; Michael J Ryan; Peter P Reese; Roland J Thorpe; Michelle Morse; Valencia Walker; Fatiu A Arogundade; Antonio A Lopes; Keith C Norris Journal: Nat Rev Nephrol Date: 2021-11-08 Impact factor: 42.439
Authors: Hilda O Hounkpatin; Simon D S Fraser; Rory Honney; Gavin Dreyer; Alison Brettle; Paul J Roderick Journal: BMC Nephrol Date: 2020-06-09 Impact factor: 2.388